@article{article, title = {{Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study}}, url = {{}}, year = {{2013}}, month = {{1}}, author = {{Awada A and Garcia AA and Chan S and Jerusalem GHM and Coleman RE and Huizing MT and Mehdi A and O'Reilly SM and Hamm JT and Barrett-Lee PJ and Cocquyt V et al}}, doi = {{10.1016/S1470-2045(13)70429-7}}, journal = {{The Lancet Oncology}}, note = {{Accessed on 2025/10/10}}}